These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 16953148
1. Gastric precancerous changes: carcinogenesis, clinical behaviour immunophenotype study and surveillance. Testino G. Panminerva Med; 2006 Jun; 48(2):109-18. PubMed ID: 16953148 [Abstract] [Full Text] [Related]
3. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis? Meining A, Morgner A, Miehlke S, Bayerdörffer E, Stolte M. Best Pract Res Clin Gastroenterol; 2001 Dec; 15(6):983-98. PubMed ID: 11866488 [Abstract] [Full Text] [Related]
4. Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori. Sawaya M, Yoshimura T, Shimoyama T, Munakata A, Fukuda S. J Clin Gastroenterol; 2008 Apr; 42(4):351-5. PubMed ID: 18277906 [Abstract] [Full Text] [Related]
5. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa]. Walecka-Kapica E, Knopik-Dabrowicz A, Klupińska G, Chojnacki J. Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262 [Abstract] [Full Text] [Related]
6. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. de Vries AC, Haringsma J, Kuipers EJ. Helicobacter; 2007 Feb; 12(1):1-15. PubMed ID: 17241295 [Abstract] [Full Text] [Related]
7. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies. Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, Bernal-Sahagún F, Abdo-Francis JM, Aguirre-García J, Muñoz N, Torres J. Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521 [Abstract] [Full Text] [Related]
9. Role of Helicobacter pylori infection and chronic inflammation in gastric cancer in the cardia. Egi Y, Ito M, Tanaka S, Imagawa S, Takata S, Yoshihara M, Haruma K, Chayama K. Jpn J Clin Oncol; 2007 May; 37(5):365-9. PubMed ID: 17578895 [Abstract] [Full Text] [Related]
10. Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway. Farinati F, Cardin R, Cassaro M, Bortolami M, Nitti D, Tieppo C, Zaninotto G, Rugge M. Eur J Cancer Prev; 2008 Jun; 17(3):195-200. PubMed ID: 18414189 [Abstract] [Full Text] [Related]
13. Review article: Helicobacter pylori eradication for the prevention of gastric cancer. De Vries AC, Kuipers EJ. Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():25-35. PubMed ID: 18081646 [Abstract] [Full Text] [Related]
14. Helicobacter pylori infection, glandular atrophy, intestinal metaplasia and topography of chronic active gastritis in the Nepalese and Japanese population: the age, gender and endoscopic diagnosis matched study. Matsuhisa T, Miki M, Yamada N, Sharma SK, Shrestha BM. Kathmandu Univ Med J (KUMJ); 2007 Dec; 5(3):295-301. PubMed ID: 18604043 [Abstract] [Full Text] [Related]
19. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia. Watari J, Das KK, Amenta PS, Tanabe H, Tanaka A, Geng X, Lin JJ, Kohgo Y, Das KM. Clin Gastroenterol Hepatol; 2008 Apr; 6(4):409-17. PubMed ID: 18321787 [Abstract] [Full Text] [Related]
20. Risk factors in gastric cancer. Compare D, Rocco A, Nardone G. Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):302-8. PubMed ID: 20496539 [Abstract] [Full Text] [Related] Page: [Next] [New Search]